POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)
1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TAJ_A_NBOA700_1
(LACTOTRANSFERRIN)		1k4q GLUTATHIONE
REDUCTASE
(Homo
sapiens)		4 / 7THR A 156
GLY A 158
PRO A 293
ASN A 294
FAD  A 499 (-3.9A)
None
None
FAD  A 499 ( 4.5A)
0.86A21.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TAJ_A_NBOA700_1
(LACTOTRANSFERRIN)		1kwm PROCARBOXYPEPTIDASE
B
(Homo
sapiens)		4 / 7THR A 129
GLY A 115
ASN A 112
GLY A  44
None
0.82A20.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TAJ_A_NBOA700_1
(LACTOTRANSFERRIN)		1n76 LACTOFERRIN
(Homo
sapiens)		5 / 7GLY A 434
PRO A 595
ASN A 596
TYR A 662
GLY A 664
None
0.43A41.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TAJ_A_NBOA700_1
(LACTOTRANSFERRIN)		1pks PHOSPHATIDYLINOSITOL
3-KINASE P85-ALPHA
SUBUNIT SH3 DOMAIN
(Homo
sapiens)		4 / 7GLY A  67
ASN A  57
GLY A  71
THR A  72
None
0.85A13.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TAJ_A_NBOA700_1
(LACTOTRANSFERRIN)		1suv SEROTRANSFERRIN,
C-LOBE
(Homo
sapiens)		5 / 7GLY E 424
PRO E 580
ASN E 581
TYR E 647
GLY E 649
None
0.40A58.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TAJ_A_NBOA700_1
(LACTOTRANSFERRIN)		1zli CARBOXYPEPTIDASE B
(Homo
sapiens)		4 / 7THR A 129
GLY A 115
ASN A 112
GLY A  44
None
0.86A24.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TAJ_A_NBOA700_1
(LACTOTRANSFERRIN)		2csp RIM BINDING PROTEIN
2
(Homo
sapiens)		5 / 7THR A  97
GLY A  57
PRO A  73
GLY A  48
THR A  47
None
1.15A18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TAJ_A_NBOA700_1
(LACTOTRANSFERRIN)		2d7t ANTI
POLYHYDROXYBUTYRATE
ANTIBODY FV, HEAVY
CHAIN
(Homo
sapiens)		5 / 7GLY H  56
PRO H  53
TYR H  33
GLY H  31
THR H  28
None
1.34A15.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TAJ_A_NBOA700_1
(LACTOTRANSFERRIN)		2hau SEROTRANSFERRIN
(Homo
sapiens)		5 / 7GLY A 425
PRO A 583
ASN A 584
TYR A 650
GLY A 652
None
0.74A32.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TAJ_A_NBOA700_1
(LACTOTRANSFERRIN)		3hig AMILORIDE-SENSITIVE
AMINE OXIDASE
(Homo
sapiens)		4 / 7THR A 491
GLY A 494
GLY A 366
THR A 369
None
0.74A19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TAJ_A_NBOA700_1
(LACTOTRANSFERRIN)		3q5e ATLASTIN-1
(Homo
sapiens)		4 / 7GLY A  33
TYR A  92
GLY A 109
THR A 108
None
0.71A21.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TAJ_A_NBOA700_1
(LACTOTRANSFERRIN)		3skp SEROTRANSFERRIN
(Homo
sapiens)		5 / 7GLY A 425
PRO A 583
ASN A 584
TYR A 650
GLY A 652
None
None
None
None
SO4  A 683 (-3.4A)
0.73A60.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TAJ_A_NBOA700_1
(LACTOTRANSFERRIN)		3wso F-BOX ONLY PROTEIN
44
(Homo
sapiens)		5 / 7GLY A 219
PRO A 217
TYR A 216
GLY A 189
THR A 190
None
1.42A21.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TAJ_A_NBOA700_1
(LACTOTRANSFERRIN)		4bla MALTOSE-BINDING
PERIPLASMIC PROTEIN,
SUPPRESSOR OF FUSED
HOMOLOG
(Escherichia
coli;
Homo
sapiens)		5 / 7GLY A   6
PRO A 272
ASN A 273
GLY A  55
THR A  54
None
1.36A19.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TAJ_A_NBOA700_1
(LACTOTRANSFERRIN)		4bv6 APOPTOSIS-INDUCING
FACTOR 1,
MITOCHONDRIAL
(Homo
sapiens)		4 / 7THR A 260
GLY A 262
PRO A 402
ASN A 403
FAD  A1449 (-4.1A)
None
None
FAD  A1449 ( 4.5A)
0.82A20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TAJ_A_NBOA700_1
(LACTOTRANSFERRIN)		4iml CROSSED HEAVY CHAIN
(VH-CKAPPA)
(Homo
sapiens)		5 / 7GLY H  56
PRO H  53
TYR H  33
GLY H  31
THR H  28
None
1.40A20.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6CI6_A_NBOA606_1
(SERUM ALBUMIN)		1tf0 SERUM ALBUMIN
(Homo
sapiens)		8 / 12ASN A 391
PHE A 403
ARG A 410
LYS A 414
VAL A 433
GLY A 434
LEU A 453
SER A 489
None
0.84A87.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6CI6_A_NBOA606_1
(SERUM ALBUMIN)		1tf0 SERUM ALBUMIN
(Homo
sapiens)		8 / 12ASN A 391
PHE A 403
TYR A 411
LYS A 414
VAL A 433
GLY A 434
LEU A 453
SER A 489
None
0.68A87.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CI6_A_NBOA606_1
(SERUM ALBUMIN)		3e0j DNA POLYMERASE
SUBUNIT DELTA-2
(Homo
sapiens)		5 / 12PHE A 410
VAL A 426
GLY A 411
LEU A 424
SER A 444
None
1.43A11.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CI6_A_NBOA606_1
(SERUM ALBUMIN)		4jon CENTROSOMAL PROTEIN
OF 170 KDA
(Homo
sapiens)		5 / 12VAL A  39
GLY A  90
SER A  36
LEU A  34
SER A  10
None
1.37A21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CI6_A_NBOA606_1
(SERUM ALBUMIN)		5eu6 HUMAN TCR HEAVY
CHAIN
(Homo
sapiens)		5 / 12PHE E 215
TYR E 189
VAL E  13
GLY E 217
LEU E 115
None
1.30A16.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CI6_A_NBOA607_1
(SERUM ALBUMIN)		1qag UTROPHIN ACTIN
BINDING REGION
(Homo
sapiens)		4 / 7ASN A  92
ALA A  89
LYS A  61
LEU A  67
None
1.04A17.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CI6_A_NBOA607_1
(SERUM ALBUMIN)		2bex RIBONUCLEASE
INHIBITOR
(Homo
sapiens)		4 / 7ALA A  58
LYS A  88
GLU A 116
LEU A 111
None
0.89A11.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CI6_A_NBOA607_1
(SERUM ALBUMIN)		3f6q LIM AND SENESCENT
CELL
ANTIGEN-LIKE-CONTAIN
ING DOMAIN PROTEIN 1
(Homo
sapiens)		4 / 7ASN B  25
LYS B  22
GLU B  33
LEU B  30
None
0.82A25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CI6_A_NBOA607_1
(SERUM ALBUMIN)		4pki GELSOLIN,TROPOMODULI
N-1 CHIMERA
(Homo
sapiens)		4 / 7ALA G1217
LYS G1221
GLU G1250
LEU G1254
None
0.88A16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CI6_A_NBOA607_1
(SERUM ALBUMIN)		5cvo WD REPEAT-CONTAINING
PROTEIN 48
(Homo
sapiens)		5 / 7ASN A  34
ALA A  48
GLU A 301
LYS A 299
LEU A 298
None
1.21A9.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CI6_A_NBOA607_1
(SERUM ALBUMIN)		5hzv MALTOSE-BINDING
PERIPLASMIC
PROTEIN,ENDOGLIN
(Escherichia
coli;
Homo
sapiens)		4 / 7ASP A 725
ALA A 729
LYS A 556
LEU A 559
None
0.94A8.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CI6_A_NBOA607_1
(SERUM ALBUMIN)		5hzw MALTOSE-BINDING
PERIPLASMIC
PROTEIN,ENDOGLIN
(Escherichia
coli;
Homo
sapiens)		4 / 7ASP A 413
ALA A 417
LYS A 244
LEU A 247
None
1.03A8.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CI6_A_NBOA607_1
(SERUM ALBUMIN)		5iy9 DNA-DIRECTED RNA
POLYMERASE II
SUBUNIT RPB1
(Homo
sapiens)		4 / 7ASP A1249
ASN A1251
ALA A1252
GLU A1188
None
1.08A3.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CI6_A_NBOA607_1
(SERUM ALBUMIN)		5jzi HCV1406 TCR ALPHA
CHAIN
(Homo
sapiens)		4 / 7ASN D  63
ALA D  64
LYS D  60
GLU D  57
None
0.93A16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CI6_A_NBOA607_1
(SERUM ALBUMIN)		5mju EXCITATORY AMINO
ACID TRANSPORTER
1,NEUTRAL AMINO ACID
TRANSPORTER
B(0),EXCITATORY
AMINO ACID
TRANSPORTER 1
(Homo
sapiens)		4 / 7ALA A  82
LYS A 280
GLU A 283
LEU A  68
None
0.81A9.20